Jeff Evanson, Chief Commercial Officer: Outlook Therapeutics OTLK Sell · Filed 23/01/19

Trade details

Type: Insider sale
Amount: $35,582.22
Shares · price: 27,162 sh · $1.31 a share
Held after: 1,149,968 sh
Stock: Outlook Therapeutics OTLK
Person: Jeff EvansonChief Commercial Officer
Trade date: 23/01/17
Filed: 23/01/19
Days to filing: 2 days

Sold 2.3% of holdings

Share of holding sold: 2.3%

Outlook Therapeutics trades, last 26 weeks

What else happened in Outlook Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/18~23/02/16

Jeff Evanson's recent trades

Jeff EvansonChief Commercial Officer
BuyOutlook Therapeutics
Buy
Outlook Therapeutics
OTLK
$26.2K
62,484 sh
$26.2K
Filed 24/03/11
Traded 24/03/07
Jeff EvansonChief Commercial Officer
SellOutlook Therapeutics
Sell
Outlook Therapeutics
OTLK
$296.4K
267,000 sh
$296.4K
Filed 23/01/24
Traded 23/01/20
Jeff EvansonChief Commercial Officer
SellOutlook Therapeutics
Sell
Outlook Therapeutics
OTLK
$126K
103,255 sh
$126K
Filed 23/01/19
Traded 23/01/19
Jeff EvansonChief Commercial Officer
SellOutlook Therapeutics
Sell
Outlook Therapeutics
OTLK
$42.2K
33,738 sh
$42.2K
Filed 23/01/19
Traded 23/01/18